Open access, medical economics journal. Publishing leading studies that determine the cost-effectiveness of treatment and high-quality economic assessments
Explore our latest review examining the impact of avoiding or delaying progression to metastatic castration-resistant #prostatecancer on quality of life, #mortality, and #economicoutcomes.
Click here to view the article in full π https://t.co/ZWdyE1GUnH
After months of hard work, our SCD-PED economic cost model manuscript is now officially published in @JME_Journal. The burden of pediatric AKI is tremendous at nearly $400,000 per hospitalization.
But our SCD-PED is estimated to save almost $70,000 per hospitalization.
https://t.co/rfP5BlugXL
Our latest article examines πππ¨πππ's cost-effectiveness compared to other long-acting insulins, including glargine, detemir, and degludec. Discover the authors' findings by clicking the link π https://t.co/Fw7iJ9R7LF
#diabetes#costeffectiveness#healtheconomics#HEOR
π’ πΉππππππππ ππ ππππ
Discover the impact of treatment failure for #migraine on lost earnings among #triptan non-responders in the general population of #Denmark. Click the link for the full article π https://t.co/WWiQulUlGT
π¨ππ¨π° π¨π§π₯π’π§ππ¨
Our latest article evaluates the budgetary impact of pathways using cT1 versus SoC (liver biopsy or VCTE) to assign suspected #MASH patients to #resmetirom. Graphical abstract available below.
Click here for the full article π https://t.co/meIwknT5qx
π’ π±πππ πππππππππ : Our latest article assesses the economic impact of #influenzavaccination across the #UAE and #Iraq. Click the link to access it in full.
πhttps://t.co/sXHtK5t37G
Congratulations to the authorsβit was lovely to collaborate with you. #HEOR
We're excited to announce that our website now features a multimedia section showcasing our #videoabstracts. Access this content hereπ https://t.co/nVzzyT6QhI
We have also expanded the extenders we offer to include #podcasts, and #videoarticles. Get in touch to find out more.
π¨ ππππ¨π¦π¦ππ§πππ π«ππππ¨
Discover the preference of #patients and #physicians for treatments of #HepatitisC infections in Japan in this article.
Click the link for the full article π https://t.co/YzsTfk6gw6
What will shape #pharmacoeconomics in 2026? Your expert opinion matters! Take our quick survey, share your perspective, and be in for a chance to win a $40 Amazon gift voucher.
Click here for the survey π https://t.co/88LDMMZF3O
#HEOR#healtheconomics#medicaleconomics
π’ Your expert opinion on #pharmacoeconomics trends for 2026 matters! Complete our short survey to share your views, and be in for a chance to win a $40 Amazon gift voucher.
Click the link to have your say π https://t.co/88LDMMZF3O
#HEOR#healtheconomics#medicaleconomics
Looking ahead to 2026: Which #pharmacoeconomics topics will have the most impact? Share your expertise in this discussion by completing our brief survey π https://t.co/e5MNKKP9LI
The results will be shared in an upcoming article in T&F's health economics journals.
#HEOR
π¨New Articleπ¨
Read our latest article titled "Use of external data to inform overall survival extrapolation in NICE technology appraisals for oncology drugs".
Click to view the article in fullπ https://t.co/Jq8dkeHUxp
#HEOR#Healtheconomics#NICE#technologyappraisals
π’ Exciting opportunity for researchers!
Adding a #graphicalabstract to your article captures a greater audience and increases views. See an excellent example below, to read the article in full, click here π
https://t.co/9pcC32EWJa
π¨New article alertπ¨
Our latest article looks at the associations between procedural volume, costs, and outcomes of septal reduction therapies for #obstructivehypertrophiccardiomyopathy in US hospitals. To read it in full, click the link π https://t.co/QykZ8k5ldG
#HEOR
π¨Journal newsπ¨
Delighted to announce that Ishveen Chopra has joined our #EarlyCareerPanel. Ishveen is a seasoned leader in #HEOR, with a distinctive background spanning clinical, translational, and analytical research. We are excited to work with Ishveen to support her career.